257 related articles for article (PubMed ID: 6846965)
1. DNA flow cytometry of pleural effusions. Comparison with pathology for the diagnosis of malignancy.
Evans DA; Thornthwaite JT; Ng AB; Sugarbaker EV
Anal Quant Cytol; 1983 Mar; 5(1):19-27. PubMed ID: 6846965
[TBL] [Abstract][Full Text] [Related]
2. Comparison of DNA flow cytometric analysis of body cavity fluids with conventional cytology.
Lima CE; Mizushima Y; Masuda S; Kitagawa M
In Vivo; 1994; 8(3):359-62. PubMed ID: 7803718
[TBL] [Abstract][Full Text] [Related]
3. Multiparameter flow cytometric DNA analysis of effusions: a prospective study of 36 cases compared with routine cytology and immunohistochemistry.
Joseph MG; Banerjee D; Harris P; Gibson S; McFadden RG
Mod Pathol; 1995 Aug; 8(6):686-93. PubMed ID: 8532707
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of flow cytometric immunophenotyping and DNA analysis for detection of malignant cells in serosal cavity fluids.
Sayed DM; el-Attar MM; Hussein AA
Diagn Cytopathol; 2009 Jul; 37(7):498-504. PubMed ID: 19217060
[TBL] [Abstract][Full Text] [Related]
5. Chromosome analysis in effusions as a diagnostic adjunct to cytology.
Augustus M; Visveshwara RN; Bhargava MK
Indian J Cancer; 1989 Jun; 26(2):67-75. PubMed ID: 2592000
[TBL] [Abstract][Full Text] [Related]
6. Detection of tumor cells in body cavity fluids by flow cytometric and immunocytochemical analysis.
Krishan A; Ganjei-Azar P; Jorda M; Hamelik RM; Reis IM; Nadji M
Diagn Cytopathol; 2006 Aug; 34(8):528-41. PubMed ID: 16850481
[TBL] [Abstract][Full Text] [Related]
7. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
8. Complementary value of DNA flow cytometry and image morphometry in detection of malignant cells in effusion fluids.
Bisht B; Handa U; Mohan H; Lehl SS
Malays J Pathol; 2014 Aug; 36(2):83-90. PubMed ID: 25194530
[TBL] [Abstract][Full Text] [Related]
9. Benign and malignant cells in effusions: diagnostic value of image DNA cytometry in comparison to cytological analysis.
Decker D; Stratmann H; Springer W; Schwering H; Varnai N; Bollmann R
Pathol Res Pract; 1998; 194(11):791-5. PubMed ID: 9842638
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric DNA analysis of pleural effusions.
Huang MS; Tsai MS; Wang TH; Lin MS; Chong IW; Chen KL; Hwang JJ
Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Dec; 8(12):640-6. PubMed ID: 1296045
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic value of DNA, RNA and proliferating cell nuclear antigen examination in malignant pleural effusions by flow cytometry].
Wang LX; Chen WX; Wu J; Chen SX; Huang XY; Chen YF
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Dec; 29(12):804-7. PubMed ID: 17327081
[TBL] [Abstract][Full Text] [Related]
12. Image analysis and flow cytometric DNA studies of benign and malignant body cavity fluids: reappraisal of the role of current methods in the differential diagnosis of reactive versus malignant conditions.
Lazcano O; Chen LM; Tsai C; Li CY; Katzmann JA; Sebo TJ; Kimlinger TK; Baker J
Mod Pathol; 2000 Jul; 13(7):788-96. PubMed ID: 10912939
[TBL] [Abstract][Full Text] [Related]
13. Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion.
Benlloch S; Galbis-Caravajal JM; Martín C; Sanchez-Paya J; Rodríguez-Paniagua JM; Romero S; Mafe JJ; Massutí B
Cancer; 2006 Oct; 107(8):1859-65. PubMed ID: 16983705
[TBL] [Abstract][Full Text] [Related]
14. Cytology, immunopathology and flow cytometry in the diagnosis of pleural and peritoneal effusions.
Croonen AM; van der Valk P; Herman CJ; Lindeman J
Lab Invest; 1988 Jun; 58(6):725-32. PubMed ID: 3288807
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric analysis and cytopathology of body cavity fluids.
Stonesifer KJ; Xiang JH; Wilkinson EJ; Benson NA; Braylan RC
Acta Cytol; 1987; 31(2):125-30. PubMed ID: 3469844
[TBL] [Abstract][Full Text] [Related]
16. Role of DNA flow cytometry and immunocytochemical analysis in diagnosis of malignant effusions.
Kundu R; Handa U; Mohan H
Diagn Cytopathol; 2012 Oct; 40(10):887-92. PubMed ID: 21485027
[TBL] [Abstract][Full Text] [Related]
17. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
18. [Significance of FCM-DNA ploidy pattern, AgNOR counting, hTERT and PCNA expression in differentiating malignant from benign serous effusion].
Wu LY; Liu BR; Lu J; Ling MD; Chen J; Li P; Jiang Y
Ai Zheng; 2007 Feb; 26(2):178-82. PubMed ID: 17298749
[TBL] [Abstract][Full Text] [Related]
19. Interphase nucleolar organizer regions in the evaluation of serosal cavity effusions.
Carrillo R; Sneige N; el-Naggar AK
Acta Cytol; 1994; 38(3):367-72. PubMed ID: 8191825
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of chromosome examination in the diagnosis of malignant pleural effusions.
Dewald G; Dines DE; Weiland LH; Gordon H
N Engl J Med; 1976 Dec; 295(27):1494-500. PubMed ID: 995156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
